Abstract
Disturbances of erythrocyte and placental membrane functiond have been studied in placenta of pregnant women with obesity and diabetes mellitus type 2. The results of this study demonstrate significant metabolic impairments in women with insulin resistance. Changes in lipid spectrum of erythrocyte membranes and decreased activity of antioxidant enzymes obviously contribute to the development of fetoplacental insufficiency. This changes point to necessity of the antioxidant therapy in pregnant women with obesity and diabetes mellitus type 2.
MeSH terms
-
Adult
-
Antioxidants / metabolism
-
Diabetes Mellitus, Type 2 / metabolism
-
Enzymes / metabolism
-
Erythrocyte Membrane / chemistry
-
Erythrocyte Membrane / metabolism*
-
Female
-
Glucosephosphate Dehydrogenase / metabolism
-
Humans
-
Insulin Resistance*
-
Lipid Peroxidation
-
Membrane Lipids / metabolism*
-
Obesity / metabolism*
-
Phospholipids / chemistry
-
Phospholipids / metabolism
-
Placenta / metabolism*
-
Pregnancy
-
Pregnancy Complications / metabolism
-
Pregnancy Trimester, Third
-
Pregnancy in Diabetics / metabolism*
-
Thyroxine / metabolism
-
Triiodothyronine / metabolism
Substances
-
Antioxidants
-
Enzymes
-
Membrane Lipids
-
Phospholipids
-
Triiodothyronine
-
Glucosephosphate Dehydrogenase
-
Thyroxine